EquityZen Growth Technology Fund LLC - Series 1843
Raised
$210K
Investors
6
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1843 is a Delaware-formed pooled investment vehicle filed by EquityZen Advisors LLC and Philip Haslett. The fund raised $210K from 6 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's platform of over 1,889 pre-IPO secondary market SPVs.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pattern typical of privately-marketed secondary market funds. The $10K minimum is accessible for qualified retail accredited investors, positioning it at the lower end of the pre-IPO investment spectrum compared to institutional-only vehicles that often require $100K+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
